TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Go back to TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
(NASDAQ: TMDX) Delayed: 81.07 +0.79 (0.98%)
Previous Close $80.28    52 Week High $ 
Open $80.96    52 Week Low $ 
Day High $83.90    P/E N/A 
Day Low $80.56    EPS $ 
Volume 962,659